REGENXBIO Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $161.7M | $24.8M |
| FY2017 | — | $183.0M | $46.7M |
| FY2018 | — | $508.8M | $75.6M |
| FY2019 | — | $450.2M | $69.5M |
| FY2020 | — | $377.8M | $338.4M |
| FY2021 | — | $764.3M | $345.2M |
| FY2022 | — | $516.2M | $97.0M |
| FY2023 | — | $311.7M | $34.5M |
| FY2024 | — | $259.7M | $57.5M |
| FY2025 | — | $102.7M | $34.5M |